Ketamine has potential therapeutic role in adolescents with treatment-resistant depression

(Mary Ann Liebert, Inc./Genetic Engineering News) A new study has shown a significant average decrease in the Children's Depression Rating Scale (42.5 percent) among adolescents with treatment-resistant depression (TRD) who were treated with intravenous ketamine.